spiramycin Search Results


92
TargetMol spiramycin
Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.
Spiramycin, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin/pmc11143517-31-14-21
Average 92 stars, based on 1 article reviews
spiramycin - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

86
Toronto Research Chemicals spiramycin i d3
Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.
Spiramycin I D3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin+I/pm22154158-45-8-18
Average 86 stars, based on 1 article reviews
spiramycin i d3 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology spiramycin
Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.
Spiramycin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin/pmc07150629-283-13-15
Average 90 stars, based on 1 article reviews
spiramycin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Toronto Research Chemicals spiramycin d 3
Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.
Spiramycin D 3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin+I-d3/pmc05534202-318-5-20
Average 90 stars, based on 1 article reviews
spiramycin d 3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

91
Selleck Chemicals spiramycin
Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.
Spiramycin, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin+I/pm38124427-175-7-19
Average 91 stars, based on 1 article reviews
spiramycin - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

95
Toronto Research Chemicals spiramycin d3
Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.
Spiramycin D3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin+I-d3/pm30836250-58-1-21
Average 95 stars, based on 1 article reviews
spiramycin d3 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology aspm
a , aPKCζ at the ventricular surface is decreased in <t>Aspm−/−</t> mice. b , Depletion of ASPM in H4 cells prevents recruitment of aPKCζ <t>and</t> <t>PAR6α</t> to the centrosomes. c , ASPM and aPKCζ co-immunoprecipitate from Hela cells. d , e , Loss of Aspm decreases ventricular surface staining for Ninein. f , Depletion of ASPM and aPKCζ prevents recruitment of Ninein to the centrosomes in H4 cells. g , Levels of aPKCζ, Par6α, and Ninein are unchanged in Aspm−/− mouse embryonic fibroblasts. See Methods for reproducibility. For gel source data, see . Scale bars: a , 50 μm; b – f , 5 μm.
Aspm, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Acetyl+Spiramycin/pmc06095461-220-24-22
Average 90 stars, based on 1 article reviews
aspm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
Thermo Fisher spr invitrogen
a , aPKCζ at the ventricular surface is decreased in <t>Aspm−/−</t> mice. b , Depletion of ASPM in H4 cells prevents recruitment of aPKCζ <t>and</t> <t>PAR6α</t> to the centrosomes. c , ASPM and aPKCζ co-immunoprecipitate from Hela cells. d , e , Loss of Aspm decreases ventricular surface staining for Ninein. f , Depletion of ASPM and aPKCζ prevents recruitment of Ninein to the centrosomes in H4 cells. g , Levels of aPKCζ, Par6α, and Ninein are unchanged in Aspm−/− mouse embryonic fibroblasts. See Methods for reproducibility. For gel source data, see . Scale bars: a , 50 μm; b – f , 5 μm.
Spr Invitrogen, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin/10__1094_slash_mpmi___02___15___0027___fi-566-176-177
Average 92 stars, based on 1 article reviews
spr invitrogen - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
TargetMol acetylspiramycin
a , aPKCζ at the ventricular surface is decreased in <t>Aspm−/−</t> mice. b , Depletion of ASPM in H4 cells prevents recruitment of aPKCζ <t>and</t> <t>PAR6α</t> to the centrosomes. c , ASPM and aPKCζ co-immunoprecipitate from Hela cells. d , e , Loss of Aspm decreases ventricular surface staining for Ninein. f , Depletion of ASPM and aPKCζ prevents recruitment of Ninein to the centrosomes in H4 cells. g , Levels of aPKCζ, Par6α, and Ninein are unchanged in Aspm−/− mouse embryonic fibroblasts. See Methods for reproducibility. For gel source data, see . Scale bars: a , 50 μm; b – f , 5 μm.
Acetylspiramycin, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Acetylspiramycin/pmc11143517-31-10-21
Average 92 stars, based on 1 article reviews
acetylspiramycin - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Enamine Ltd spr measurement
a , aPKCζ at the ventricular surface is decreased in <t>Aspm−/−</t> mice. b , Depletion of ASPM in H4 cells prevents recruitment of aPKCζ <t>and</t> <t>PAR6α</t> to the centrosomes. c , ASPM and aPKCζ co-immunoprecipitate from Hela cells. d , e , Loss of Aspm decreases ventricular surface staining for Ninein. f , Depletion of ASPM and aPKCζ prevents recruitment of Ninein to the centrosomes in H4 cells. g , Levels of aPKCζ, Par6α, and Ninein are unchanged in Aspm−/− mouse embryonic fibroblasts. See Methods for reproducibility. For gel source data, see . Scale bars: a , 50 μm; b – f , 5 μm.
Spr Measurement, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin/pmc04496089-38-1-7
Average 90 stars, based on 1 article reviews
spr measurement - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Gold Biotechnology Inc telithromycin
Residence time and cellular PAE values of the macrolide ribosome inhibitors
Telithromycin, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/Spiramycin/pmc07150629-260-9-11
Average 90 stars, based on 1 article reviews
telithromycin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.

Journal: Acta Pharmaceutica Sinica. B

Article Title: Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed –1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element

doi: 10.1016/j.apsb.2024.02.023

Figure Lengend Snippet: Carrimycin inhibits hCoV replication in cells. (A) The chemical structure of carrimycin. (B) Carrimycin inhibited hCoV-229E replication under a different multiplicity of infection (MOI) detected by CCK-8 assay at 72 h of drug treatment. Remdesivir (RDV 0.02 μmol/L) as a positive control. (C) Carrimycin inhibited hCoV-229E (MOI = 0.03) at the RNA levels quantified by qRT-PCR at 24 h of drug treatment. (D) Carrimycin inhibited the SARS-CoV-2 Omicron strain in Vero-E6 cells (CPE assay). (E) Anti-coronaviral activity of macrolide antibiotics. Viral dsRNA (green) and cell nuclei (blue) in Huh7 cells infected with hCoV-229E and in H460 cells infected with hCoV-OC43 visualized by immunofluorescent staining assay at 24 h of drug treatment. Scale bar: 100 μm. The experiments were carried out three times. P values were calculated using Student's t -test (mean ± SD, n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . virus control. CC 50 , 50% cytotoxic concentration; EC 50 , 50% effective concentration; TCID 50 , 50% tissue culture infective dose.

Article Snippet: Remdesivir (T7766), clarithromycin (T1434), midecamycin (T5037), erythromycin (T1032), roxithromycin (T1151), acetylspiramycin (T1557), azithromycin (T6401), spiramycin (T0819), and azathramycin (T3265) were from Topscience Co., Ltd. (Shanghai, China).

Techniques: Infection, CCK-8 Assay, Positive Control, Quantitative RT-PCR, Activity Assay, Staining, Virus, Control, Concentration Assay, Tissue

a , aPKCζ at the ventricular surface is decreased in Aspm−/− mice. b , Depletion of ASPM in H4 cells prevents recruitment of aPKCζ and PAR6α to the centrosomes. c , ASPM and aPKCζ co-immunoprecipitate from Hela cells. d , e , Loss of Aspm decreases ventricular surface staining for Ninein. f , Depletion of ASPM and aPKCζ prevents recruitment of Ninein to the centrosomes in H4 cells. g , Levels of aPKCζ, Par6α, and Ninein are unchanged in Aspm−/− mouse embryonic fibroblasts. See Methods for reproducibility. For gel source data, see . Scale bars: a , 50 μm; b – f , 5 μm.

Journal: Nature

Article Title: Aspm knockout ferret reveals an evolutionary mechanism governing cerebral cortical size

doi: 10.1038/s41586-018-0035-0

Figure Lengend Snippet: a , aPKCζ at the ventricular surface is decreased in Aspm−/− mice. b , Depletion of ASPM in H4 cells prevents recruitment of aPKCζ and PAR6α to the centrosomes. c , ASPM and aPKCζ co-immunoprecipitate from Hela cells. d , e , Loss of Aspm decreases ventricular surface staining for Ninein. f , Depletion of ASPM and aPKCζ prevents recruitment of Ninein to the centrosomes in H4 cells. g , Levels of aPKCζ, Par6α, and Ninein are unchanged in Aspm−/− mouse embryonic fibroblasts. See Methods for reproducibility. For gel source data, see . Scale bars: a , 50 μm; b – f , 5 μm.

Article Snippet: The following antibodies were used at 1:100 – 1:2000: Centrin (Millipore 20H5), Par6α (SCBT sc-14405), Par6α (Abcam ab180159), β-actin (Proteintech 20536-1-AP), ASPM (SCBT sc-98903), ASPM (gift from J.

Techniques: Staining

Residence time and cellular PAE values of the macrolide ribosome inhibitors

Journal: ACS infectious diseases

Article Title: Correlating Drug-Target Residence Time and Post-Antibiotic Effect: Insight into Target Vulnerability

doi: 10.1021/acsinfecdis.9b00484

Figure Lengend Snippet: Residence time and cellular PAE values of the macrolide ribosome inhibitors

Article Snippet: Erythromycin was obtained from Sigma-Aldrich, azithromycin from TCI America, telithromycin from Gold biotechnology, spiramycin from Santa Cruz Biotech and tylosin from Alfa Aesar.

Techniques:

Input and output values of thermodynamic and kinetic parameters for the selected macrolides.

Journal: ACS infectious diseases

Article Title: Correlating Drug-Target Residence Time and Post-Antibiotic Effect: Insight into Target Vulnerability

doi: 10.1021/acsinfecdis.9b00484

Figure Lengend Snippet: Input and output values of thermodynamic and kinetic parameters for the selected macrolides.

Article Snippet: Erythromycin was obtained from Sigma-Aldrich, azithromycin from TCI America, telithromycin from Gold biotechnology, spiramycin from Santa Cruz Biotech and tylosin from Alfa Aesar.

Techniques: